(Q46825473)

25 December 2017

title

Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas (English)

1 reference

25 December 2017

1 reference

1 reference

7

Edward A Neuwelt

1 reference

25 December 2017

David Fortin

6

object named as

David Fortin

1 reference

25 December 2017

author name string

Walter A Hall

1

1 reference

25 December 2017

Nancy D Doolittle

2

1 reference

25 December 2017

Megan Daman

3

1 reference

25 December 2017

Patti K Bruns

4

1 reference

25 December 2017

Leslie Muldoon

5

1 reference

25 December 2017

publication date

29 November 2005

1 reference

25 December 2017

Journal of Neuro-Oncology

published in

1 reference

25 December 2017

volume

77

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

279-284

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-005-9038-4

exact match

0 references

cites work

First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate

1 reference

12 December 2020

Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.

1 reference

12 December 2020

The results of radiotherapy for brainstem tumors.

1 reference

12 December 2020

Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.

1 reference

12 December 2020

Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group.

1 reference

12 December 2020

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

1 reference

12 December 2020

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma

1 reference

12 December 2020

Brainstem Gliomas. A 10-year institutional review

1 reference

12 December 2020

Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood?

1 reference

12 December 2020

Diffuse medulla oblongata and pontine gliomas in childhood. A review of 37 cases

1 reference

12 December 2020

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

1 reference

12 December 2020

1 reference

12 December 2020

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

1 reference

12 December 2020

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherap

1 reference

12 December 2020

Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors

1 reference

12 December 2020

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

1 reference

12 December 2020

10.1007/S11060-005-9038-4

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017